Join
Live feed
·
SECFilingvia Quantisnow
UroGen Pharma Ltd. logo

UroGen Pharma Ltd. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
URGN· UroGen Pharma Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track URGN (UroGen Pharma Ltd.) and more on Quantisnow.